{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-120637","form_type":"8-K","ticker":"VYNE","cik":"0001566044","company_name":"VYNE Therapeutics Inc.","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.769290+00:00","generated_at":"2026-05-16T13:21:16.312664+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"VYNE Therapeutics annual meeting elects directors, ratifies auditor, approves say-on-pay","bullets":["Class I directors Elisabeth Sandoval Little and Steven Basta elected with ~3.9M votes each.","Baker Tilly US, LLP ratified as independent auditor for FY 2024 with 15.3M votes for.","Advisory vote on named executive officer compensation passed with 4.6M votes for.","Quorum of 50.1% of 33.3M shares outstanding at meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-120637","json":"https://secwatch.observer/filing/0001104659-25-120637.json","markdown":"https://secwatch.observer/filing/0001104659-25-120637.md","text":"https://secwatch.observer/filing/0001104659-25-120637.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925120637/0001104659-25-120637-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925120637/tm2533382d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:21:16.312664+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}